Raleigh Capital Management Inc. Charles River Laboratories International, Inc. Transaction History
Raleigh Capital Management Inc.
- $253 Million
- Q4 2024
A detailed history of Raleigh Capital Management Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 14 shares of CRL stock, worth $2,434. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 17
17.65%
Holding current value
$2,434
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
53.9MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1.07 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$885 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$709 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$379 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$314 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.84B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...